Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23244551 | 1.00 | MAP3K5 (1.00) | MAP3K5 | |
| SCHEMBL23244552 | 1.00 | MAP3K5 (1.00) | MAP3K5 | |
| SCHEMBL23244561 | 1.00 | MAP3K5 (1.00) | MAP3K5 | |
| SCHEMBL23244553 | 0.90 | MAP3K5 (0.82) | MAP3K5 | |
| SCHEMBL23244564 | 0.89 | MAP3K5 (0.79) | MAP3K5 | |
| SCHEMBL23244548 | 0.89 | MAP3K5 (0.79) | MAP3K5 | |
| SCHEMBL23244545 | 0.89 | MAP3K5 (0.79) | MAP3K5 | |
| SCHEMBL23244601 | 0.88 | MAP3K5 (0.79) | MAP3K5 | |
| SCHEMBL23244602 | 0.88 | MAP3K5 (0.79) | MAP3K5 | |
| SCHEMBL23244558 | 0.88 | MAP3K5 (1.00) | MAP3K5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240109867-A1 | ASK1 INHIBITING AGENTS | BIOGEN MA INC. | 2024-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109867-A1 | ASK1 INHIBITING AGENTS | MAP3K1, MAP3K10, MAP3K20 | MAP3K5 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.